FORTE Update for May 2024 Newsletter

May 14 2024

FORTE enrolled its 1400th participant on April 9, 2024!

Thanks to the efforts of investigators and clinical research professionals dedicated to NRG-CC005, we enrolled 115 participants in March 2024, our best month ever!

FORTE Site Establishment Funding Application

NRG offers a one-time site network start-up fee of $5,000 to enhance recruitment. Sites that document preparation and commitment to the FORTE trial are eligible. The funds are to assist in establishing a clinical referral population and to institute workflows to facilitate recruitment and enrollment. Funding is contingent upon review by the NRG FORTE leadership team. If your site is funded, payment will be issued to the site.

Find the application form on CTSU with the post date of April 3, 2024, under NRG-CC006 – Protocol Related Documents.

Accrual Updates and Milestones (as of April 30, 2024)

Top accruing sites:

  • Kaiser Permanente – Vallejo – 835 accrued
  • UPMC-Presbyterian Hospital – 213 accrued
  • Regions Hospital – 77 accrued

Most recent randomizations:

  • Stanford Cancer Institute Palo Alto – April 30, 2024
  • Midwestern Regional Medical Center – April 30, 2024
  • UCHealth University of Colorado Hospital – April 29, 2024
  • Zablocki Veterans Administration Medical Center – April 29, 2024

Recent Trial-Wide Monthly Accrual:

  • February 2024 – 85 participants
  • March 2024 – 115 participants
  • April 2024 – 90 participants

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:
1(800) 477-7227

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.